Expression and characterization of dog CYP2D15 using baculovirus expression system

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Cytochrome P450 enzymes (CYPs) are crucial for drug metabolism.
• Understanding species-specific CYP variations, like dog CYP2D15, is vital for drug development.
• Previous research has identified various CYP2D subfamilies with differing substrate specificities.

Purpose of the Study:

• To express functional dog CYP2D15 in a heterologous system.
• To characterize the catalytic activity and substrate specificity of expressed dog CYP2D15.
• To compare the activity of dog CYP2D15 with other CYP2D enzymes and native dog liver microsomes.

Main Methods:

• Recombinant baculovirus expression of dog CYP2D15 in Sf9 insect cells.
• Characterization of expressed P450 using CO-difference spectroscopy.
• Enzyme kinetic assays for substrate hydroxylation and N-demethylation.
• Western blot analysis to estimate CYP2D15 levels in dog liver.

Main Results:

• Successfully expressed functional dog CYP2D15 protein in Sf9 cells.
• Expressed CYP2D15 exhibited high catalytic activity for bunitrolol and imipramine hydroxylation at low concentrations.
• Demonstrated extremely low debrisoquine hydroxylation activity compared to other CYP2D species.
• Showed high imipramine N-demethylation activity.
• Dog liver microsomes also metabolized bunitrolol and imipramine but not debrisoquine.
• Dog CYP2D15 constitutes less than 4% of total liver P450 content.

Conclusions:

• Expressed dog CYP2D15 possesses high catalytic activity but unique substrate specificity within the CYP2D subfamily.
• Dog CYP2D15's metabolic profile differs significantly from other known CYP2D enzymes.
• The findings highlight the importance of species-specific CYP characterization in pharmaceutical research.